Skip to main content

Advertisement

Log in

Serum Vascular Endothelial Growth Factor as a Possible Prognostic Indicator in Sarcoidosis

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Sarcoidosis is a systemic granulomatous disorder of unknown etiology, which involves the lung, eye, liver, and other organs. Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis involved in an important role in the development of granuloma. However, only a limited number of studies have reported on the relationship between serum VEGF values and the clinical status of sarcoidosis. Concentrations of serum VEGF were determined in 33 patients with sarcoidosis. We investigated the correlation between serum VEGF values and extent of disease, prognosis, and radiographic stage compared with serum angiotensin converting enzyme (ACE) values as another candidate. Concentrations of serum VEGF in patients who received corticosteroid treatment were significantly higher than those of patients with spontaneous remission (p < 0.05). In addition, serum VEGF values in patients with extrathoracic involvements were significantly higher than those of patients with sarcoid lesions limited to the thoracic space (p < 0.05), accompanied by a tendency to increase the number of organs involved. The values of serum ACE revealed no relationship to the values of serum VEGF, administration of corticosteroid, or extrathoracic involvements. We concluded that serum VEGF values in patients with sarcoidosis is a predictive factor in determining extrathoracic organ involvements and as a parameter for deciding the necessity of treatment with corticosteroid. Serum VEGF might be a useful marker as a prognostic indicator in sarcoidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. S Nagai M Shigematsu K Hamada T Izumi (1999) ArticleTitleClinical courses and prognoses of pulmonary sarcoidosis. Curr Opin Pulm Med 5 293–298 Occurrence Handle10.1097/00063198-199909000-00005 Occurrence Handle1:STN:280:DyaK1MzptVKgtg%3D%3D Occurrence Handle10461533

    Article  CAS  PubMed  Google Scholar 

  2. HF Dvorak LF Brown M Detmar AM Dvorak (1995) ArticleTitleVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 1029–1039 Occurrence Handle1:CAS:528:DyaK2MXmt1Kkt7g%3D Occurrence Handle7538264

    CAS  PubMed  Google Scholar 

  3. S Takano Y Yoshii S Kondo H Suzuki T Maruno S Shirai T Nose (1996) ArticleTitleConcentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56 2185–2190 Occurrence Handle1:CAS:528:DyaK28Xis1ektbY%3D Occurrence Handle8616870

    CAS  PubMed  Google Scholar 

  4. T Griga A Tromm J Spranger B May (1998) ArticleTitleIncreased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33 504–508 Occurrence Handle1:STN:280:DyaK1czhtFehtg%3D%3D Occurrence Handle9648990

    CAS  PubMed  Google Scholar 

  5. W Matsuyama T Hashiguchi K Matsumuro F Iwami Y Hirotsu M Kawabata K Arimura M Osame (2000) ArticleTitleIncreased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 162 1120–1122 Occurrence Handle1:STN:280:DC%2BD3cvotFaiug%3D%3D Occurrence Handle10988140

    CAS  PubMed  Google Scholar 

  6. CG Li I Reynolds JM Ponting PJ Holt MC Hillarby S Kumar (1998) ArticleTitleSerum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis. Br J Rheumatol 37 1303–1306 Occurrence Handle10.1093/rheumatology/37.12.1303 Occurrence Handle1:STN:280:DyaK1M7jslCguw%3D%3D Occurrence Handle9973154

    Article  CAS  PubMed  Google Scholar 

  7. R Bragado E Bello L Requena G Renedo E Texeiro MV Alvarez MA Castilla C Caramelo (1999) ArticleTitleIncreased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 79 422–425 Occurrence Handle10.1080/000155599750009834 Occurrence Handle1:CAS:528:DC%2BD3cXlt1yjuro%3D Occurrence Handle10598753

    Article  CAS  PubMed  Google Scholar 

  8. E Tolnay C Kuhnen B Voss T Wiethege KM Muller (1998) ArticleTitleExpression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 432 61–65 Occurrence Handle10.1007/s004280050135 Occurrence Handle1:CAS:528:DyaK1cXjtlSmtg%3D%3D Occurrence Handle9463589

    Article  CAS  PubMed  Google Scholar 

  9. GW Hunninghake U Costabel M Ando R Baughman JF Cordier R du Bois A Eklund M Kitaichi J Lynch G Rizzato C Rose O Selroos G Semenzato OP Sharma (1999) ArticleTitleATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 149–173 Occurrence Handle1:STN:280:DC%2BD3c%2Fitl2isg%3D%3D Occurrence Handle10560120

    CAS  PubMed  Google Scholar 

  10. KC Meyer A Cardoni ZZ Xiang (2000) ArticleTitleVascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135 332–338 Occurrence Handle1:CAS:528:DC%2BD3cXjtVGks7k%3D Occurrence Handle10779049

    CAS  PubMed  Google Scholar 

  11. K Iwai M Sekiguti Y Hosoda RA DeRemee HD Tazelaar OP Sharma A Maheshwari TI Noguchi (1994) ArticleTitleRacial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11 26–31 Occurrence Handle1:STN:280:ByuA3M%2FislY%3D Occurrence Handle8036339

    CAS  PubMed  Google Scholar 

  12. E Yamaguchi A Itoh N Hizawa Y Kawakami (2001) ArticleTitleThe gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 119 753–761 Occurrence Handle10.1378/chest.119.3.753 Occurrence Handle1:CAS:528:DC%2BD3MXisFSmt7o%3D Occurrence Handle11243953

    Article  CAS  PubMed  Google Scholar 

  13. M Petrek J Drabek V Kolek J Zlamal KI Welsh M Bunce E Weigl R Du Bois (2000) ArticleTitleCC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162 1000–1003 Occurrence Handle1:STN:280:DC%2BD3cvotFWqug%3D%3D Occurrence Handle10988120

    CAS  PubMed  Google Scholar 

  14. A Pietinalho K Furuya E Yamaguchi Y Kawakami O Selroos (1999) ArticleTitleThe angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 13 723–726 Occurrence Handle10.1034/j.1399-3003.1999.13d04.x Occurrence Handle1:STN:280:DyaK1M3ovVyktA%3D%3D Occurrence Handle10362030

    Article  CAS  PubMed  Google Scholar 

  15. H Tomita S Sato R Matsuda Y Sugiura H Kawaguchi T Niimi S Yoshida M Morishita (1999) ArticleTitleSerum lysozyme levels and clinical features of sarcoidosis. Lung 177 161–167 Occurrence Handle1:STN:280:DyaK1M3gvVyjtQ%3D%3D Occurrence Handle10192763

    CAS  PubMed  Google Scholar 

  16. J Muller-Quernheim (1998) ArticleTitleSerum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 15 22–37 Occurrence Handle1:STN:280:DyaK1c3jtlGhtA%3D%3D Occurrence Handle9571999

    CAS  PubMed  Google Scholar 

  17. U Costabel H Teschler (1997) ArticleTitleBiochemical changes in sarcoidosis. Clin Chest Med 18 827–842 Occurrence Handle1:STN:280:DyaK1c%2FnsFGrsA%3D%3D Occurrence Handle9413661

    CAS  PubMed  Google Scholar 

  18. J Katada M Muramatsu I Hayashi M Tsutsumi Y Konishi M Majima (2002) ArticleTitleSignificance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 302 949–956 Occurrence Handle10.1124/jpet.102.034231 Occurrence Handle1:CAS:528:DC%2BD38XmsF2hsLk%3D Occurrence Handle12183651

    Article  CAS  PubMed  Google Scholar 

  19. U Costabel (2001) ArticleTitleSarcoidosis: clinical update. Eur Respir J (suppl) 32 56s–68s Occurrence Handle1:STN:280:DC%2BD38%2FovVeksw%3D%3D

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Sekiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekiya, M., Ohwada, A., Miura, K. et al. Serum Vascular Endothelial Growth Factor as a Possible Prognostic Indicator in Sarcoidosis . Lung 181, 259–265 (2003). https://doi.org/10.1007/s00408-003-1028-8

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-003-1028-8

Keywords

Navigation